Pfizer Inc
NYSE: PFE
▲
33.84
+0.01
+0.01%
1 Day
-
Open
33.85
-
Previous Close
33.83
-
Volume (Avg)
974.60k (19.48M)
-
Day's Range
33.82-33.95
-
52Wk Range
28.25-37.39
-
Market Cap.
205.20B
-
Dividend Rate (Yield)
1.20 (3.55%)
-
Beta
0.87
-
Shares Outstanding
6.07B
-
P/E Ratio (EPS)
29.94 (1.13)
Top Stories
-
BRIEF-Pfizer completes acquisition of Medivation
Reuters 1 hr ago* Co increased its regular quarterly cash dividend to $0.23 per share Source text for Eikon: Further company coverage: BRUSSELS, Sept 28 EU antitrust regulators opened an investigation into Deutsche Boerse's proposed $28 billion merger with the London ...
-
Pfizer Staying Together, Valeant Breaking Up - A Rangeley Capital Portfolio Manager Discussion
Seeking Alpha -
BRIEF-IHS Markit to terminate previously authorized $500 million share repurchase program
Reuters -
BRIEF-Pfizer to showcase progress of broad-based oncology portfolio at ESMO 2016 Congress
Reuters -
Pfizer's 9% Decline Gives Dividend Investors Buying Opportunity
Seeking Alpha 20 hrs agoPfizer stock has taken a dip since the company announced it would not break itself up, preferring instead to remain a single entity. This may be viewed as a disappointment, but there is no need to mess with a good thing. Pfizer's M&A and organic growth ...
-
Fitch Affirms Ratings on Pfizer (PFE) Amid Decision to Remain Whole
StreetInsider -
Pfizer (PFE) to Stay Together as a Single Company After All
NASDAQ -
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
The Motley Fool -
Pfizer Throws Out Plan to Split Into Two Companies
The Wall Street Journal -
Opko Health Has Big News on Deck
The Motley Fool -
Moody's Affirms Pfizer's (PFE) Ratings Amid Decision Not to Split Company
StreetInsider -
Pfizer decides against split-up; more deals seen likely
Reuters -
Pfizer eschews proposal to split into two
USA Today -
Pfizer Remains Whole, but the Option to Split Could Return
New York Times -
Pfizer’s pricey non-split may only defer problem
Reuters 1 day ago -
Pfizer won't split
Reuters -
Pfizer Won’t Split, Ending Years of Speculation About Drug Giant
Bloomberg -
UPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company
Stockhouse
